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Abstract
This prospective study aimed to evaluate whether Contralateral compensatory testicular
hypertrophy (CTH) is valid as a predictive tool for a non-viable testis in children aged
between 6 and 18 months, and whether CTH is affected by mini-puberty. Seventy-two tes-
tes from 60 boys aged between 6 and 18 months were categorized into three groups: 24
testes contralateral to surgically removed non-viable testes (NVTs), 24 testes contralateral
to surgically corrected undescended testes (UDTs), and 24 testes from a normal controls.
Contralateral testicular length and volume were measured with ultrasonography and com-
pared among the groups. Group 1 (NVT) had a significantly longer length and larger volume
than group 2 (UDT). The length and volume of each group among three developmental peri-
ods (6–10, 10–14, and 14–18 months) were also analyzed. In the controls, the length was
significantly larger at 6–10 months than at 10–14 months in accordance with previously
reported changes in testicular size due to the effect of “mini-puberty.” The volume of con-
trols showed a similar pattern, though without statistical significance. However, this pattern
was not observed in the NVT and UDT groups. A receiver operating curve revealed that a
testicular length of 16.1 mm or a volume of 0.59 ml had the highest sensitivity and specificity
for predicting NVTs. The CTH was also found to be valid as a predictive tool for a NVT in
children of ages 6 to 18 months, as the effect of mini-puberty appeared to be absent in the
NVT and UDT groups. However, the cut-off values were less than those of previous reports.
The proper cut-off level according to the age and measurement method should be applied
in this developmental period.
Introduction
Contralateral compensatory testicular hypertrophy (CTH) in patients with a non-viable testis
(NVT) is a well-known phenomenon.[1] The mechanism of CTH is attributable to increased
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gonadotropin (mainly follicle stimulating hormone [FSH]) secretion associated with positive
feedback induced by the undeveloped affected testis.[1, 2] The degree of CTH in terms of the
testicular length or volume has been reported to predict the viability of the affected testis in
children with a non-palpable testis.[2–6] Hurwitz and Kaptein reported a testicular length of
18 mm in the contralateral testis as a cut-off value for an ipsilateral NVT in children under the
age of 11 years,[2] and Shibata et al. reported a cut-off of 2.2 ml of contralateral testicular vol-
ume in children under the age of 5 years.[5]
However, for the preservation of fertility, recent guidelines recommend surgical correction
of undescended testes as early as possible, starting after 6 months of age and before 18 months
of age.[7, 8] Moreover, testicular volume changes due to the unstable level of gonadotropic hor-
mones, also known as mini-puberty,[9, 10] could confuse clinicians using the previous cut-off
value during infancy. Therefore, to determine the most appropriate cut-off value for CTH as a
predictive tool, an evaluation of these early-aged children is mandatory. We hypothesized that
CTH is also valid as a predictive tool for an NVT even in children aged 6–18 months, though
with a different cut-off level. To validate this hypothesis, we performed a prospective study in
this age group. We additionally analyzed whether CTH is affected by mini-puberty.
Materials and Methods
Patients
A prospective study was carried out in accordance with the Declaration of Helsinki after receiv-
ing study approval from the Severance Hospital Institutional Review Board (4-2014-0385) and
registering the trial at www.clinicaltrials.gov (NCT02203318).
A notice for the clinical study was posted on the bulletin board at our institution, and all
participants including controls were voluntarily recruited at their parents’ request. Informed
consent was obtained from the parents or legal guardians in written form. Sixty boys aged
between 6 and 18 months, who visited our tertiary referral hospital between June 2014 and
April 2015 due to cryptorchidism, were enrolled in this study. A total of 72 testes, including 24
contralateral testes (24 patients) from those with a surgically removed unilateral NVT (group
1), 24 contralateral testes (24 patients) from those with a surgically corrected unilateral unde-
scended testis (UDT; group 2), and 24 testes (12 patients) from normal controls (group 3),
were included in this study. The categorization of groups 1 and 2 was only made with the oper-
ative findings. NVT was diagnosed when a blind-ending spermatic vessel was identified in the
abdomen, inguinal canal, or scrotum during operation and was also confirmed histopathologi-
cally after excision. Thus, a testis was categorized into group 2 when a viable UDT was found
during an operation, even when the diagnosis of a non-palpable testis was made before the
operation. Exclusion criteria were: having a known chromosomal abnormality; history of hor-
mone therapy; history of a previous surgery in either the abdomen, inguinal, or genital area;
history of a urinary tract infection; retractile testis; or history of epididymo-orchitis.
Study design
Using a pairwise comparison method, we determined the sample size necessary to achieve sta-
tistically reliable results with the minimal number of participants using Shibata et al.’s study,[5]
which had reported mean testicular volumes of 2.20 ml and 1.10 ml for the NVT and UDT
groups, respectively. Standard deviation was conservatively assumed to be 1.0. According to a
two-sided, two-sample equal-variance t-test, a sample size of 24 for each group was obtained.
The sample size achieved 90% power to reject the null hypothesis of equality with a standard
deviation of 1.0 and a significance level (alpha) of 0.017. An alpha value of 0.0167 (0.05/
3 = 0.0167) was conservatively selected to control for type I error from three pairwise
Contralateral Testicular Hypertrophy in Infancy
PLOS ONE | DOI:10.1371/journal.pone.0151528 March 18, 2016 2 / 11
comparisons [group 1 (NVT) vs. group 2 (UDT), group 2 (UDT) vs. control, and control vs.
group 1(NVT)]. Testicular length and volume were compared among the groups. To verify the
presence of size changes during the infantile period, we subdivided each group into three sub-
groups by age (6–10 months, 10–14 months, and 14–18 months, respectively) and made a
comparison of the testicular lengths and volumes.
Testis size and volume measurement
Wemeasured testicular size with ultrasonography, with the children lying in a supine position
with spread legs.[9] The testicular volumes were calculated using a mathematical formula to
measure the volume of an ellipsoid: length × width × height × (π/6).[9] To decrease the inter-
observer variability, measurement in this study was performed by single investigator (HSS).
Statistical analysis
Categorical and continuous variables were compared using Fisher’s exact test and the Kruskal-
Wallis test, respectively. To compare the testicular volumes and lengths among the three
groups, a post hoc evaluation was conducted using the Mann-Whitney U test with Bonferroni
correction. As the 24 control testes were from 12 control patients, we performed a sensitivity
analysis that also used the Mann-Whitney U test with Bonferroni correction to determine that
each testis was independent from the others. To establish the cut-off value predicting a NVT, a
receiver operating characteristic (ROC) curve was constructed. Statistical significance was
defined when the p value was less than 0.05. These statistical analyses were conducted with
SPSS software, version 18.0 (IBM Corp., Armonk, NY, USA).
Results
Among the 31 patients with a non-palpable testis, viable UDTs were confirmed during laparos-
copy and inguinal exploration in 7 patients. These 7 patients were categorized into group 2,
along with 17 patients with palpable UDTs located in the inguinal canal.
Compensatory testicular hypertrophy in 6- to 18-month-old infants
The median age at evaluation was 11.5 (inter-quartile range [IQR], 8.8–14.4) months. The
median age was not different among the three groups (p = 0.358; Table 1).
The median testicular length and volume were significantly different among the groups
(p< 0.001 and p< 0.001, respectively). A post hoc evaluation using the Mann-Whitney U test
revealed that group 1 (NVT) had a significantly longer length and larger volume than group 2
(UDT; p< 0.001 and p< 0.001, respectively; Fig 1A and 1B). After a sensitivity analysis of the
mean testicular length and volume of each of the 12 controls, we found the same pattern as
with the 24 control testes.
Testicular size changes at 6–18 months of age in each group
We additionally analyzed whether changes in testicular size were observed in each group
between 6 and 18 months. In group 1 (NVT) and group 2 (UDT), there was no significant dif-
ference in testicular length or volume during the three time periods (Fig 2A–2D). However, in
controls (group 3), the length of the testes was significantly longer in infants at 6–10 months
than at 10–14 months (p = 0.015; Fig 2E). The median testicular volume of the control group
in infants at 6–10 months was larger than at 10–14 months, though without statistical signifi-
cance (Fig 2F). After a sensitivity analysis of the mean testicular length and volume of each of
the 12 controls, we found the same pattern as with the 24 control testes.
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Determination of the cut-off value for testicular length and volume
predictive of a non-viable contralateral testis
To set the cut-off level for testicular length and volume predicting a NVT, the sensitivity and
specificity for each length and volume was calculated among the 48 testes of group 1 (NVT)
Table 1. Characteristics of 72 testes in 60 patients.
Variable Group 1/NVT (24 testes in 24
patients)
Group 2/UDT (24 testes in 24
patients)
Group 3/Control (24 testes in 12
patients)
p
Value
Laterality (R:L) 17:7 13:11 12:12 0.322
Palpable testis 0 17 24 <0.001
Median age at
evaluation (months)
(IQR)
12.7 (9.5–14.4) 10.9 (8.2–13.3) 11.7 (8.3–16.6) 0.381
Age distribution in
each group
0.835
6–10 months 7 11 8
10–14 months 9 7 8
14–18 months 8 6 8
Median length (mm)
(IQR)
6–18 months 17.8 (16.1–18.9) 14.7 (13.4–16.0) 13.5 (11.0–15.6) <0.001
6–10 months 16.2 (15.7–17.7) 14.4 (13.3–16.0) 15.7 (13.5–15.8) 0.055
10–14
months
18.0 (16.6–18.6) 14.6 (14.0–16.2) 11.2 (10.7–14.8) 0.001
14–18
months
19.1 (15.7–20.2) 15.5 (12.5–16.4) 12.8 (10.7–15.0) 0.007
Median volume (ml)
(IQR)
6–18 months 0.82 (0.66–1.07) 0.53 (0.39–0.61) 0.44 (0.35–0.59) <0.001
6–10 months 0.71 (0.61–0.89) 0.53 (0.39–0.58) 0.58 (0.46–0.80) 0.053
10–14
months
0.79 (0.60–0.98) 0.52 (0.47–0.58) 0.36 (0.30–0.54) 0.008
14–18
months
0.99 (0.84–1.17) 0.57 (0.34–0.72) 0.42 (0.35–0.58) 0.003
NVT: non-viable testis; UDT: undescended testis; IQR: interquartile range; Categorical and continuous variables were compared using Fisher’s exact test
and the Kruskal-Wallis test, respectively.
doi:10.1371/journal.pone.0151528.t001
Fig 1. Median testicular length (A) and volume (B) were compared and showed significant differences
among the groups. Post hoc evaluation using the Mann-Whitney U test revealed that group 1 (NVT) had a
significantly longer length and larger volume than group 2 (UDT).
doi:10.1371/journal.pone.0151528.g001
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and group 2 (UDT). When the testicular length was 16.1 mm (sensitivity 75.0%, specificity
79.2%) or volume was 0.59 ml (sensitivity 83.3%, specificity 75.0%), the combination of
Fig 2. The variation of testicular length and volume during infancy by the effect of mini-puberty was
absent in both NVTs and UDTs. In group 1 (NVT) (A-B) and group 2 (UDT) (C-D), there was no significant
difference in testicular length or volume during any of the three periods assessed. In group 3 (controls), the
length of the testes was significantly longer in infants at 6–10 months than at 10–14 months (E). The median
testicular volume of the control group in infants at 6–10 months was larger than at 10–14 months, though
without statistical significance (F).
doi:10.1371/journal.pone.0151528.g002
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sensitivity and specificity was maximal. We constructed a ROC curve based on these values
(Fig 3). The area under the curve was calculated as 85.9% with testicular length and 83.3% with
testicular volume.
Fig 3. When testicular length was 16.1 mm (sensitivity 75.0%, specificity 79.2%) and volume was 0.59 ml (sensitivity 83.3%, specificity 75.0%), the
combination of sensitivity and specificity wasmaximal. The area under the curve was calculated as 85.9% (95% confidence interval: 75.7%–96.2%) for
testicular length and 83.3% (95% confidence interval: 71.8%–94.9%) for testicular volume.
doi:10.1371/journal.pone.0151528.g003
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Discussion
Previously, the optimal cut-off value for prediction of a NVT was 20.0 mm in length and 2.0 ml
in volume based on report by Koff et al. (Table 2).[3] Recently, Braga et al. proposed 19.0–20.0
mm in length.[6] Both the recommended testicular length and volume cut-offs in these studies
were larger than the values in our study (16.1 mm for length and 0.59 ml for volume). There
are a few differences between the previous reports and our study, including the method of mea-
surement, age at evaluation, and patient grouping for calculating cut-off values. First, the dis-
crepancy in volume was more prominent than that in length. Also, volume was not measured
in three dimensions, or the information was not sufficient in previous reports. Koff measured
the volume directly using an orchidometer, or indirectly calculated from the orchidometer by
comparing the length of the long axis of the testis with the long axis of an orchidometer tem-
plate of known testicular volume.[3] Shibata et al. used a caliper, but the method of volume
measurement was not written in their report.[5] In contrast, the volume was measured in three
dimensions in our study using ultrasonography. Kuijper et al. reported that the testes at early
ages are not equivalent in shape; therefore, measurement in one plane may not represent the
true volume.[9] Moreover, Sakamoto et al. demonstrated that a testicular ultrasound is more
accurate than an orchidometer in assessing the testicular volume without overestimation.[13]
Ultrasound can also exclude the inappropriate inclusion of the epididymis, scrotal skin, and
adjacent soft tissue during the measurement.[14, 15] From this point of view, our study may
achieve a greater precision than previous cut-off values of volume. A discrepancy in the age at
evaluation could be a fundamental cause for differences between our findings and other pub-
lished studies. Our study included the youngest group of patients among all the reports. Even a
few months of age difference could result in a significant difference in testicular length and vol-
ume at this age. A proper cut-off level should be applied according to the patient age, especially
Table 2. Cut-off level for testicular length and volume reported previously.
Included Age at evaluation Measurement methods Cut-off value
Length Volume Length Volume
Koff (1991)[3] 12 NVT 8 months-3years Caliper or ruler Takihara orchidometer or conversion
of length into volume
20 mm 2.0 ml
25 UDT
Hurwitz and Kaptein
(2001)[2]
40 NVT 7 month-11years Conversion of volume to
length and/or ruler
Takihara orchidometer 18 mm N/A
16 UDT
Snodgrass et al.
(2007)[11]
28 NVT Median 23 (6–154)
months
Ruler N/A 18 mm N/A
12 UDT
Shibata et al. (2010)
[5]
33 NVT Mean 19.4 (8–46)
months
Caliper N/A 22.4 mm 2.2 ml
22 UDT
Braga et al. (2014)
[6]
35 NVT Mean 28.0 ± 17.6
months
Caliper Not measured 19–20
mm
N/A
50 UDT
Hodhod et al.(2015)
[12]
46 NVT Median 19.7 (8.4–
109.4) months
N/A Takihara orchidometer N/A 2.0 ml
26 UDT
Current study 24 NVT 11.5 (IQR: 8.8–14.4)
months
Ultrasonography Ultrasonography 16.1 mm 0.59 ml
24 UDT
NVT: non-viable testis, UDT: viable undescended testis, N/A: not available, IQR: inter-quartile range
doi:10.1371/journal.pone.0151528.t002
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in infancy. Nevertheless, the previous studies that calculated cut-off values had investigated
heterogeneous patients with broad ranges of ages. This difference seems to be the reason why
our cut-off values are different from theirs.
In this study, we calculated the cut-off level among 48 testes of non-palpable or palpable
inguinal testes. In contrast, previous reports only included non-palpable testes in the analysis
of cut-off values. In our study, 24 testes were proven to be NVTs among 31 preoperative non-
palpable testes. We calculated the cut-off level among 48 testes, including 24 non-palpable and
non-viable testes, 7 non-palpable and viable testes, and 17 palpable and viable testes. In con-
trast, Braga et al. included only preoperative non-palpable testes. However, among 85 non-pal-
pable testes in their study, the proportion of NVTs was only 35. In the study by Koff et al., the
authors similarly limited their inclusion criteria to only preoperative non-palpable testes, and
only subsequently discovered 12 surgically proven NVTs. Therefore, a total of 120 NVTs and
113 UDTs were analyzed in the calculation of the recommended cut-off levels in the previous
four reports. In conclusion, the composition of 24 NVTs and 24 UDTs in our study seemed
similar to the previous reports, even though we included palpable testes.
Serum FSH, luteinizing hormone (LH), and testosterone levels begin to increase during the
second week after birth, reaching a maximum level at approximately 4–10 weeks, and then
decline by approximately 6 months of age to a low pre-pubertal level until the onset of puberty.
[10, 16] This hormonal surge is the result of a transient spurt in the hypothalamic gonadotro-
pin-releasing hormone pulse generator-pituitary gonadotropin-gonadal apparatus within a few
minutes after birth, after being freed from the estrogenic inhibitory effect.[16] In this period,
Sertoli cells are stimulated by FSH to produce a protein called Inhibin B.[17] In normal infants,
the serum level of Inhibin B increases as a response to the incremental increase in serum FSH
level and the resultant expansion in Sertoli cell numbers.[18, 19] Inhibin B controls the level of
FSH secretion by a negative feedback mechanism. The serum level of Inhibin B remains ele-
vated longer than the neonatal surge of FSH, LH, and testosterone, and is present at a detect-
able level until 15 months of age.[10] In early infancy, the testes are mainly composed of Sertoli
cells, and the increase in testicular volume is mainly associated with an increase in seminiferous
tubule length due to the proliferation of Sertoli cells stimulated by FSH.[20] Associated with
the aforementioned fluctuation of hormonal levels or so-called ‘mini-puberty,’ testicular vol-
ume may also change. Kuijper et al. measured testicular volume with ultrasonography in nor-
mal children aged 0 to 6 years.[9] They revealed that testicular volume increases from birth to
5 months of age. Following this period, the volume declines and reaches a minimum level at
approximately 9 months of age, with no further distinct size changes until 6 years of age. Our
results in the control group are consistent with those of Kuijper et al.
Nevertheless, this effect of a ‘mini-puberty’ in our study was not observed in patients with a
NVT or UDT. In the children with a NVT, even though the early activation of the hypotha-
lamic-pituitary-gonadal hormone axis is intact, the decreased number of germ cells and Sertoli
cells of the affected testes may induce a decreased total serum level of Inhibin B.[18] The rela-
tively lower negative feedback may induce an unimpeded rise in the FSH level, which influ-
ences the growth of the seminiferous tubules in the contralateral testis, causing the resultant
testicular enlargement. We observed a gradual increase in testicular size from the normal con-
trol group to the NVT group. This difference may have been due to the difference in the
amount of testicular tissue affected. These observations corresponded to the findings reported
by previous studies, demonstrating a correlation between the degree of the defect in the affected
testis and the extent of CTH.[2–4]
The CTH related to the affected testicular volume could be also applied to the UDT group,
along with another possible mechanism. Unlike with an NVT, a UDT could be related to a
defect in the LH-Leydig cell axis. Several studies have proven that the levels of LH and
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testosterone between 1–4 months of age are significantly lower than normal in children with
UDTs.[21–25] Previously, it was reported that the surge of plasma gonadotropins and testos-
terone in children with UDTs is lower than that of children with normal testes.[21, 26, 27] This
phenomenon could be applied in the UDT group before 6 months of age. Although our results
did not achieve statistical significance, the median value of testicular length and volume were
smaller in group 2 (UDT) than in group 3 (control) at 6–10 months (Table 1). Following this
period, a decreased number of Sertoli cells in the UDT group might have produced a smaller
amount of negative feedback and caused the testes to be larger after 10 months of age.
One limitation of our study lies in the absence of corresponding data about plasma gonado-
tropins, Inhibin B, and testosterone to explain whether hormonal effects were actually present
or not. Another limitation is an insufficient number of patients for the analysis of the testicular
size variation according to the subdivided age groups, as our initial primary end-point was to
compare testicular size among the three groups rather than to make subdivisions by age. In
addition, to decrease the interobserver variability, measurements in this study were performed
by single investigator. Further evaluation by multiple investigators is mandatory.
Nevertheless, we analyzed whether CTH is also effective during 6–18 months of age, the
most important period in clinical practice according to recent guidelines. CTH was validated
even in this period, but with different cut-off values. Moreover, a subgroup analysis revealed
the absence of the effect of the so-called ‘mini-puberty’ on testicular volume in the NVT group
for the first time, to our knowledge. Ultrasonographic measurement in our study could also be
helpful for the correct measurement, as mentioned above. Further study with endocrinological
evidence and serial follow-up evaluation on the testicular size could yield more information.
Conclusions
The CTH in patients with an NVT or a UDT is also valid as a predictive tool for a non-viable
testis even at 6–18 months after birth, as the effect of mini-puberty is absent in these patient
groups. However, the cut-off values for testicular length and volume predicting the absence of
viable testes are less than those of previous reports with older patients. Applying the proper
cut-off level according to the age and measurement method is necessary, especially in infancy.
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